Company Name: Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of antibiotics for multidrug-resistant (MDR) infections. The company’s lead product candidate is a broad-spectrum intravenous and oral antibiotic designed to treat multidrug-resistant infections (including MDR Gram-negative infections).
Ticker Symbol: TTPH (NASDAQ)
Company Website: http://tphase.com
Headquarters: Watertown, MA